RBRenato Baserga

Renato Baserga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Renato Baserga has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Hongzhi Sun

    Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA

    3 shared publications
  • Marco Prisco

    Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

    3 shared publications
  • An Wu

    ‡Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 and the §Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, Pennsylvania 19122

    2 shared publications
  • George Adrian Calin

    The University of Texas MD Anderson Cancer Center

    2 shared publications
  • Mingli Liu

    Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

    2 shared publications
  • Robert Drakas

    Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

    2 shared publications

Latest Publications

  • The role of insulin receptor substrate‐1 in transformation by v‐src

    by Hongzhi Sun, Renato Baserga

    The insulin receptor substrate-1 (IRS-1), a docking protein for both the insulin (InR) and the insulin-like growth factor-1 (IGF-IR) receptors, sends a mitogenic, anti-differentiation and transforming signal. We now show that down-regulation of IRS-1 in cells transformed by v-src reverses the transformed phenotype (growth in serum-free medium and colony formation in soft agar). IRS-1 translocates to nuclei and is found in the cyclin D1 and rDNA promoters. Stat3, which is activated by src, requires both IRS-1 and src for promoter occupancy. IRS-1 (by itself or in combination with src) also markedly increases transcription from these two promoters. We also show that IRS-1 binds to src via its two PI3-K binding tyrosine residues, and that these two residues are required for transformation of mammary cancer cells expressing v-src. Taken together, these results indicate a significant role of IRS-1 in the activation of cell cycle progression genes and transformation of cells by v-src. J. Cell. Physiol. 215: 725–732, 2008.


  • Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes

    by A Wu, J Chen, R Baserga

    The insulin receptor substrate-1 (IRS-1) is a docking protein of the insulin-like growth factor-1 (IGF-1) receptor and of the insulin receptor. IRS-1 sends a strong mitogenic, anti-apoptotic signal and plays an important role in cell transformation and cancer. IRS-1 translocates to nuclei of cells, where it increases the activity of the rDNA, c-myc and cyclin D1 promoters. We show, by chromatin immunoprecipitation, occupancy by IRS-1 of the same promoters. Both promoter activation and promoter occupancy are IGF-1-dependent. In cells that respond to IGF-1 but in which IRS-1 does not translocate to nuclei, promoter occupancy is absent and promoter activation is absent or much reduced. Transcriptional activation of c-myc and cyclin D1 promoters by nuclear IRS-1 does not occur with a mutant, inactive IRS-1 protein (deletion of the phosphotyrosine-binding domain, PTB) and does not require PI3-kinase activity. Taken together, these results indicate a novel mechanism by which nuclear IRS-1 activates cell cycle genes.


  • Dual regulation of upstream binding factor 1 levels by IRS‐1 and ERKs in IGF‐1‐receptor signaling

    by Hongzhi Sun, Xiao Tu, Mingli Liu, Renato Baserga

    The Upstream Binding Factor 1 (UBF1) is a nucleolar protein that participates in the regulation of RNA polymerase I activity and ribosomal RNA (rRNA) synthesis. In 32D myeloid cells expressing the type 1 insulin‐like growth factor receptor (IGF‐IR), the UBF1 protein (but not its mRNA) is down regulated when the cells are shifted from Interleukin‐3 (IL‐3) to IGF‐1. Ectopic expression of insulin receptor substrate‐1 (IRS‐1) in these cells inhibits the down‐regulation of UBF1. We now show that the stability of UBF1 in 32D‐derived cells requires also a signal from the extracellular regulated kinases (ERKs). When ERKs signaling is defective, as in cells over‐expressing the insulin receptor (InR) or selected mutants of the IGF‐1R, UBF1 is down‐regulated, even in the presence of IRS‐1. The down‐regulation is corrected by the expression of an activated Ha‐ras, which stimulates ERKs activity. Mutations at threonines 117 and 201 of UBF1, known to be phosphorylated by ERKs, cause its down‐regulation. However, when IRS‐2, instead of IRS‐1, is ectopically expressed in 32D InR cells, ERKs phosphorylation is increased and UBF is stabilized. Taken together, these results indicate that in 32D‐derived myeloid cells expressing either the IGF‐IR or the InR, UBF1 levels are regulated by signaling from both IRS proteins and ERKs. J. Cell. Physiol. 212:780–786, 2007.


  • Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells

    by Bin Shi, Marco Prisco, George Calin, Chang‐Gong Liu, Giuseppe Russo, Antonio Giordano, Renato Baserga

    32D cells are murine myeloid cells that grow indefinitely in Interleukin‐3 (IL‐3). In these cells, the type 1 insulin‐like growth factor (IGF‐I) and granulocytic‐colony stimulating factor (G‐CSF) induce differentiation to granulocytes. 32D cells do not express insulin receptor substrate‐1 (IRS‐1) or IRS‐2, docking proteins of the IGF‐I receptor. Ectopic expression of IRS‐1 in these cells inhibits differentiation, the cells become IL‐3 independent and IGF‐1 dependent and can form tumors in mice. 32D and 32D‐derived cells offer a good model in which to study the expression profiles of Micro Rna (miR) related to sustained proliferation or differentiation. We present here the data obtained with miR micro‐arrays and identify the miR that are regulated by IGF‐1 or G‐CSF and are associated with either differentiation or indefinite cell proliferation of 32D murine myeloid cells.


  • 24p3 in differentiation of myeloid cells

    by Mingli Liu, Marco Prisco, Robert Drakas, David Searles, Renato Baserga

    24p3 is a secreted lipocalin that has been variously related to apoptosis, proliferation, and the neutrophil lineage of blood cells. We have investigated the expression of 24p3 mRNA and protein in myeloid cell lines induced to differentiate by insulin‐like growth factor 1 (IGF‐1) and the granulocytic‐colony simulating factor (G‐CSF). Both these growth factors, which cause myeloid cells to differentiate into granulocytes, induced a marked increase in the expression of both 24p3 protein and mRNA. The mRNA especially appeared early after the cells were induced with either IGF‐1 or G‐CSF, at a time when the cells were still proliferating and are morphologically undifferentiated. 24p3 can be considered an early marker of granulocytic differentiation.


  • Open Access

    Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and β-Catenin

    by Jia Chen, An Wu, Hongzhi Sun, Robert Drakas, Cecilia Garofalo, Sandra Cascio, Eva Surmacz, Renato Baserga


  • Open Access

    Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells

    by Marco Prisco, Arianna Maiorana, Clara Guerzoni, George Calin, Bruno Calabretta, Renate Voit, Ingrid Grummt, Renato Baserga

    Pescadillo (PES1) and the upstream binding factor (UBF1) play a role in ribosome biogenesis, which regulates cell size, an important component of cell proliferation. We have investigated the effects of PES1 and UBF1 on the growth and differentiation of cell lines derived from 32D cells, an interleukin-3 (IL-3)-dependent murine myeloid cell line. Parental 32D cells and 32D IGF-IR cells (expressing increased levels of the type 1 insulin-like growth factor I [IGF-I] receptor [IGF-IR]) do not express insulin receptor substrate 1 (IRS-1) or IRS-2. 32D IGF-IR cells differentiate when the cells are shifted from IL-3 to IGF-I. Ectopic expression of IRS-1 inhibits differentiation and transforms 32D IGF-IR cells into a tumor-forming cell line. We found that PES1 and UBF1 increased cell size and/or altered the cell cycle distribution of 32D-derived cells but failed to make them IL-3 independent. PES1 and UBF1 also failed to inhibit the differentiation program initiated by the activation of the IGF-IR, which is blocked by IRS-1. 32D IGF-IR cells expressing PES1 or UBF1 differentiate into granulocytes like their parental cells. In contrast, PES1 and UBF1 can transform mouse embryo fibroblasts that have high levels of endogenous IRS-1 and are not prone to differentiation. Our results provide a model for one of the theories of myeloid leukemia, in which both a stimulus of proliferation and a block of differentiation are required for leukemia development.


  • Top Cited Papers

    The IGF‐1 receptor in cancer biology

    by Renato Baserga, Francesca Peruzzi, Krysztof Reiss

    The type 1 insulin‐like growth factor receptor (IGF‐1R) plays an important role in the establishment and maintenance of the transformed phenotype. It also has a strong antiapoptotic activity and has a significant influence on the control of cell and body size. Downregulation of the IGF‐1R leads to massive apoptosis of cancer cells. These characteristics make it an attractive target for anticancer therapy.


  • Nuclear translocation of insulin receptor substrate‐1 by the insulin receptor in mouse embryo fibroblasts

    by An Wu, Laura Sciacca, Renato Baserga

    Translocation of the insulin receptor substrate‐1 (IRS‐1) to the nuclei has been reported to occur in cells stimulated by insulin‐like growth factor‐1 (IGF‐I) or expressing certain viral and cellular oncogenes. We show here that insulin can also induce nuclear translocation of IRS‐1 in mouse embryo fibroblasts (MEF), that do not express the type 1 insulin‐like growth factor receptor (IGF‐IR). Only the A isoform of the insulin receptor (IR) can induce IRS‐1 nuclear translocation, which is significant when the receptor is over‐expressed. At physiological receptor levels, translocation occurs only in a fraction of cells, and only at high concentrations of ligand.